Participated · Equity · Jul 2026

Elixir Aircraft designs and manufactures carbon-fiber light aircraft aimed at flight schools and pilot training. The company has launched a new program named Equinox as part of its product roadmap. Management is pursuing an international growth strategy and began expanding into the United States shortly before this financing. Following the €45 million round, led by SPI with a €20 million contribution, Elixir plans to ramp production with a goal of delivering nearly 60 training aircraft per year by 2027. The company has previously attracted outside investors and continues to rely on external capital to scale operations.

Participated · Series A · Jun 2026

Quobly develops silicon-based quantum processors and system-level architectures using FD-SOI technology on 300 mm wafers to enable semiconductor-grade manufacturability and dense integration. Its Alloy product line includes Alloy Pioneer, intended for early adopters in high-performance computing and research, and will be accessible through the cloud in 2026 with deployment into HPC environments planned for 2027. Quobly pairs hardware, control electronics and a software stack including Alloy Forge, its quantum application development environment, to allow developers to build and validate applications under realistic hardware constraints. The company emphasizes industrialization through partnerships with semiconductor and industrial leaders such as STMicroelectronics, Air Liquide, Soitec and Orano. Financially, Quobly completed a €19 million seed phase from 2023–2025 and has now raised a €115 million Series A to fund R&D, scaling of silicon quantum processors and commercial expansion. Its strategy centers on transferring quantum technologies into advanced manufacturing environments to address scalability, yield and reproducibility.

Led · Equity · May 2026

Faactopi builds an adaptive reconfigurable manufacturing system (AARMS) that models assembly-line configurations, creates a digital twin of the factory, and continuously optimizes production planning; the AARMS technology is proprietary and patent-pending. The company operates under a Manufacturing-as-a-Service model that lets customers industrialize without upfront capital investment and has already worked with clients including Exotrail, Luniwave, and Stereolabs. Founded by Saadia Ajana and Bertrand Joubert, both former Symbio employees, Faactopi recently moved into 1,000 m² of workshops at Usin Lyon Parilly in Vénissieux and currently employs 17 people with plans to reach 25 by end-2026. Faactopi has development partnerships with Dassault Systèmes and the LIMOS laboratory (CNRS). Financially, it has generated nearly €1 million in revenue over three years and targets €4 million in 2027 and €10 million in 2028, the latter projected as the point of profitability. The company plans to accelerate R&D, hire additional staff, and equip its factory following the recent financing, and is eyeing longer-term market expansion into agroalimentaire, cosmetics, and biotechnologies with contacts in Morocco and Japan.

Participated · Equity · Jan 2026

Founded in 2020, AI Verse has built a proprietary platform that procedurally constructs 3D scenes and delivers pixel-perfect, photorealistic images in seconds, giving AI teams fine-grained control over scene types, lighting, object frequency, and rare edge-case scenarios. Its technology combines two in-house procedural engines (interior and exterior), a custom generation architecture, an animation pipeline, and a library exceeding 6,600 3D objects. The company markets both SaaS and on-premise versions, allowing customers in sectors such as autonomous vehicles, defense, robotics, smart cities, and industrial inspection to generate data that is expensive, dangerous, or impossible to capture in the real world. After four years of R&D, AI Verse is positioned as a cost-effective alternative to manual data collection and annotation, helping clients meet privacy, diversity, and quality requirements. With the latest funding, the firm plans to hire across engineering, product, and sales, and to deepen its international presence while expanding into industrial robotics, medical imaging, and augmented reality. The leadership team blends AI and 3D-animation expertise, led by CEO Benoît Morisset (PhD in AI & robotics) and 3D veteran Arnauld Lamorlette. Although no revenue or user figures were disclosed, the company touts growing demand from defense and security customers and a roadmap focused on broader commercialization.

Led · Series A · Jan 2026

Founded in 2017, MYCOPHYTO creates bio-based agricultural inputs derived from carefully selected mycorrhizal fungi. Its proprietary, AI-driven platform designs fungal consortia adapted to specific soils and climates, boosting plants’ access to water and nutrients. Field results cited by the company show up to 20% better water retention and yield increases of up to 45% in viticulture while reducing fertilizer use. The products target farmers seeking regenerative solutions amid drought and soil degradation pressures. Proceeds from the latest financing will fund construction of MYCOPHYTO’s first industrial-scale production facility, equipped with sustainable technologies backed by the France 2030 program. The company will also reinforce operations in Spain and Morocco and expand into Côte d’Ivoire and the Benelux as it pursues broader international growth.